DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
2.800
-0.150 (-5.08%)
At close: Jul 2, 2024, 4:00 PM
2.801
+0.001 (0.04%)
After-hours: Jul 2, 2024, 7:38 PM EDT
DiaMedica Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for DMAC stock have an average target of 7.00, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 150.00% from the current stock price of 2.80.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 24, 2024.
Analyst Ratings
The average analyst rating for DMAC stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +185.71% | Apr 24, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $11 → $8 | Strong Buy | Maintains | $11 → $8 | +185.71% | Mar 21, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +114.29% | Mar 21, 2024 |
Oppenheimer | Oppenheimer | Hold → Buy Upgrades $7 | Hold → Buy | Upgrades | $7 | +150.00% | Jun 22, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +185.71% | Jul 7, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.70
from -0.60
EPS Next Year
-0.88
from -0.70
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.68 | -0.81 | -0.74 |
Avg | -0.70 | -0.88 | -0.71 |
Low | -0.73 | -0.93 | -0.69 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.